Safety and immunogenicity of inactivated whole virion vaccine CoviVac against COVID-19: a multicenter, randomized, double-blind, placebo-controlled phase I/II clinical trial

Aydar A Ishmukhametov; Aleksandra A Siniugina; Nadezhda V Yagovkina; Vladimir I Kuzubov; Konstantin A Zakharov; Viktor P Volok; Maria S Dodina; Larissa V Gmyl; Natalya A Korotina; Rostislav D Theodorovich; Yulia I Ulitina; Andrey A Tsaan; Tatiana V Pomaskina; Anna V Kalenskaya; Irina V Solovjeva; Elena V Tivanova; Larissa Y Kondrasheva; Antonina A Ploskireva; Vasiliy G Akimkin; Ksenia A Subbotina; Georgy M Ignatyev; Anastasia K Korduban; Elena Y Shustova; Ekaterina O Bayurova; Alla S Kondrashova; Darya V Avdoshina; Anastasia N Piniaeva; Anastasia A Kovpak; Liliya P Antonova; Yulia V Rogova; Anna A Shishova; Yury Y Ivin; Svetlana E Sotskova; Konstantin A Chernov; Elena G Ipatova; Ekaterina A Korduban; Liubov I Kozlovskaya; Ilya V Gordeychuk

bioRxiv (2022) - Comments
doi: 10.1101/2022.02.08.22270658

Aydar A Ishmukhametov, Aleksandra A Siniugina, Nadezhda V Yagovkina, Vladimir I Kuzubov, Konstantin A Zakharov, Viktor P Volok, Maria S Dodina, Larissa V Gmyl, Natalya A Korotina, Rostislav D Theodorovich, Yulia I Ulitina, Andrey A Tsaan, Tatiana V Pomaskina, Anna V Kalenskaya, Irina V Solovjeva, Elena V Tivanova, Larissa Y Kondrasheva, Antonina A Ploskireva, Vasiliy G Akimkin, Ksenia A Subbotina